EU/3/19/2232

About

On 16 December 2019, orphan designation EU/3/19/2232 was granted by the European Commission to MDC RegAffairs GmbH, Germany, for Lactobacillus plantarum for the treatment of amyotrophic lateral sclerosis.

Key facts

Active substance
Lactobacillus plantarum
Disease / condition
Treatment of amyotrophic lateral sclerosis
Date of first decision
16/12/2019
Outcome
Positive
EU designation number
EU/3/19/2232

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

MDC RegAffairs GmbH    
Baumberger Strasse 11  
Longerich   
50737 Cologne 
Germany
Tel: +49 (0) 221 7401339
E-mail: info@lifemaxlabs.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating